CN103961721B - 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 - Google Patents
减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 Download PDFInfo
- Publication number
- CN103961721B CN103961721B CN201410183149.8A CN201410183149A CN103961721B CN 103961721 B CN103961721 B CN 103961721B CN 201410183149 A CN201410183149 A CN 201410183149A CN 103961721 B CN103961721 B CN 103961721B
- Authority
- CN
- China
- Prior art keywords
- plasmid
- vnp20009
- salmonella typhimurium
- attenuated salmonella
- genetic engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410183149.8A CN103961721B (zh) | 2014-04-30 | 2014-04-30 | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410183149.8A CN103961721B (zh) | 2014-04-30 | 2014-04-30 | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103961721A CN103961721A (zh) | 2014-08-06 |
CN103961721B true CN103961721B (zh) | 2018-10-23 |
Family
ID=51232032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410183149.8A Active CN103961721B (zh) | 2014-04-30 | 2014-04-30 | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103961721B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105983103A (zh) * | 2015-03-17 | 2016-10-05 | 广州华津医药科技有限公司 | 基因工程菌vnp20009-m在制备预防和治疗癌症转移的药物上的应用 |
CN106474489B (zh) * | 2015-08-31 | 2019-08-16 | 广州华津医药科技有限公司 | 减毒鼠伤寒沙门氏菌基因工程菌在制备治疗肝癌药物上的应用 |
CN105802899B (zh) * | 2016-03-15 | 2022-08-02 | 中国药科大学 | 一种抑制肿瘤生长的基因工程菌及其构建方法和应用 |
CN107115533A (zh) * | 2017-04-01 | 2017-09-01 | 广州华津医药科技有限公司 | 基因工程菌vnp20009‑m在制备治疗恶性肉瘤药物中的应用 |
CN106913883A (zh) * | 2017-04-01 | 2017-07-04 | 广州华津医药科技有限公司 | 基因工程菌vnp20009‑m在制备预防和治疗肺癌药物中的应用 |
CN112190717B (zh) * | 2020-10-16 | 2023-12-15 | 广州华津医药科技有限公司 | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗急性白血病的药物上的应用 |
CN114712403B (zh) * | 2022-03-27 | 2024-05-17 | 江苏靶标生物医药研究所有限公司 | 一种减毒沙门氏菌在制备治疗肺癌胸腔积液药物中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103146626A (zh) * | 2013-02-28 | 2013-06-12 | 南京华贞生物医药科技有限公司 | 一种治疗乳腺癌的基因工程菌及其构建方法和应用 |
-
2014
- 2014-04-30 CN CN201410183149.8A patent/CN103961721B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103146626A (zh) * | 2013-02-28 | 2013-06-12 | 南京华贞生物医药科技有限公司 | 一种治疗乳腺癌的基因工程菌及其构建方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103961721A (zh) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103961721B (zh) | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 | |
CN103656684B (zh) | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗胰腺癌的药物上的应用 | |
Fu et al. | Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair | |
CN105983103A (zh) | 基因工程菌vnp20009-m在制备预防和治疗癌症转移的药物上的应用 | |
Yuan et al. | Role of the tumor microenvironment in tumor progression and the clinical applications | |
CN103146626B (zh) | 一种治疗乳腺癌的基因工程菌及其构建方法和应用 | |
CN1974759B (zh) | 运载重组质粒的减毒沙门氏菌及其在抗肿瘤中的应用 | |
Burgueño et al. | Epithelial TLR4 signaling activates DUOX2 to induce microbiota-driven tumorigenesis | |
Wang et al. | CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma | |
US11318172B2 (en) | Use of genetically engineered bacterium of attenuated Salmonella typhimurium in for treating liver cancer | |
Tian et al. | Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC | |
Li et al. | The mechanism involved in the loss of PTEN expression in NSCLC tumor cells | |
Dai et al. | Key indexes and the emerging tool for tumor microenvironment editing | |
JP2020509093A (ja) | 遺伝子工学菌vnp20009−mの肺癌予防・治療薬の製造における応用 | |
Veldwijk et al. | Comparison of the proliferative and clonogenic growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapy | |
CN112190717A (zh) | 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗急性白血病的药物上的应用 | |
CN113528427A (zh) | 一种结直肠靶向载药外泌体及应用和治疗结直肠疾病药物 | |
Li et al. | Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism | |
Yue et al. | Taraxacum mongolicum polysaccharide promotes white adipocyte browning by regulating miR-134-3p via Akt/GSK-3β signalling | |
US9439934B1 (en) | Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer | |
CN103110958B (zh) | Tt1基因在制备治疗肿瘤的药物中的应用 | |
CN107115533A (zh) | 基因工程菌vnp20009‑m在制备治疗恶性肉瘤药物中的应用 | |
CN107536845B (zh) | 一种防治肿瘤的药物及其用途 | |
CN105802899A (zh) | 一种抑制肿瘤生长的基因工程菌及其构建方法和应用 | |
Linjuan Sun et al. | NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160829 Address after: 510075 Guangdong, Guangzhou, new Guangzhou knowledge city, Phoenix Road 2, building 8, No. three, No. 2416 Applicant after: Guangzhou Huajin Pharmaceutical Technology Co.,Ltd. Address before: 211100, No. 118 East Tianyuan Road, Jiangning District, Jiangsu, Nanjing Applicant before: NANJING SINOGEN BIOTECH & PHARMACEUTICAL Inc. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 510535 Room 101, building C5, No. 11, Kaiyuan Avenue, Huangpu District, Guangzhou, Guangdong Patentee after: Guangzhou Huajin Pharmaceutical Technology Co.,Ltd. Address before: 510075 Building 2, No. 8, Fenghuang Third Road, Zhongxin Guangzhou Knowledge City, Guangzhou, Guangdong 2416 Patentee before: Guangzhou Huajin Pharmaceutical Technology Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application of attenuated Salmonella typhimurium and its genetically engineered bacteria in the preparation of drugs for the treatment of prostate cancer Effective date of registration: 20230427 Granted publication date: 20181023 Pledgee: Chepi Road Branch of Guangzhou Bank Co.,Ltd. Pledgor: Guangzhou Huajin Pharmaceutical Technology Co.,Ltd. Registration number: Y2023980039395 |